148 related articles for article (PubMed ID: 36657325)
1. Rationale for LDH-targeted cancer immunotherapy.
Miholjcic TBS; Halse H; Bonvalet M; Bigorgne A; Rouanne M; Dercle L; Shankar V; Marabelle A
Eur J Cancer; 2023 Mar; 181():166-178. PubMed ID: 36657325
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis.
Petrelli F; Ardito R; Merelli B; Lonati V; Cabiddu M; Seghezzi S; Barni S; Ghidini A
Melanoma Res; 2019 Feb; 29(1):1-12. PubMed ID: 30308577
[TBL] [Abstract][Full Text] [Related]
3. Lactate dehydrogenase: a marker of diminished antitumor immunity.
Van Wilpe S; Koornstra R; Den Brok M; De Groot JW; Blank C; De Vries J; Gerritsen W; Mehra N
Oncoimmunology; 2020; 9(1):1731942. PubMed ID: 32158624
[TBL] [Abstract][Full Text] [Related]
4. The multiple roles of LDH in cancer.
Claps G; Faouzi S; Quidville V; Chehade F; Shen S; Vagner S; Robert C
Nat Rev Clin Oncol; 2022 Dec; 19(12):749-762. PubMed ID: 36207413
[TBL] [Abstract][Full Text] [Related]
5. Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers.
Comandatore A; Franczak M; Smolenski RT; Morelli L; Peters GJ; Giovannetti E
Semin Cancer Biol; 2022 Nov; 86(Pt 2):93-100. PubMed ID: 36096316
[TBL] [Abstract][Full Text] [Related]
6. LDH-C4: a target with therapeutic potential for cancer and contraception.
Gupta GS
Mol Cell Biochem; 2012 Dec; 371(1-2):115-27. PubMed ID: 22893065
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma.
Li Y; Wang K; Zhao E; Li B; Li S; Dong X; Yuan L; Yang H
Pathol Oncol Res; 2022; 28():1610245. PubMed ID: 35721326
[No Abstract] [Full Text] [Related]
8. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
9. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis.
Giatromanolaki A; Sivridis E; Gatter KC; Turley H; Harris AL; Koukourakis MI;
Gynecol Oncol; 2006 Dec; 103(3):912-8. PubMed ID: 16837029
[TBL] [Abstract][Full Text] [Related]
10. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of lactate dehydrogenase measurements in current oncological practice.
Forkasiewicz A; Dorociak M; Stach K; Szelachowski P; Tabola R; Augoff K
Cell Mol Biol Lett; 2020; 25():35. PubMed ID: 32528540
[TBL] [Abstract][Full Text] [Related]
12. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer.
Augoff K; Hryniewicz-Jankowska A; Tabola R
Cancer Lett; 2015 Mar; 358(1):1-7. PubMed ID: 25528630
[TBL] [Abstract][Full Text] [Related]
13. Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancer.
Tjokrowidjaja A; Lord SJ; John T; Lewis CR; Kok PS; Marschner IC; Lee CK
Cancer; 2022 Apr; 128(8):1574-1583. PubMed ID: 35090047
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Trarbach T; Folprecht G; Shi MM; Lebwohl D; Jalava T; Laurent D; Meinhardt G; Harris AL
Clin Cancer Res; 2011 Jul; 17(14):4892-900. PubMed ID: 21632858
[TBL] [Abstract][Full Text] [Related]
15. Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies.
Jedlička M; Feglarová T; Janstová L; Hortová-Kohoutková M; Frič J
Front Immunol; 2022; 13():932055. PubMed ID: 36330529
[TBL] [Abstract][Full Text] [Related]
16. Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments.
Ding J; Karp JE; Emadi A
Cancer Biomark; 2017 Jul; 19(4):353-363. PubMed ID: 28582845
[TBL] [Abstract][Full Text] [Related]
17. Lactate dehydrogenase as promising marker for prognosis of brain metastasis.
Pei YY; Zhang Y; Liu ZR; He Y; Yu JY; Zhang RJ; Wang JJ; Peng XC; Fang F
J Neurooncol; 2022 Sep; 159(2):359-368. PubMed ID: 35794505
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ
Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma.
Wei XL; Zhang DS; He MM; Jin Y; Wang DS; Zhou YX; Bai L; Li ZZ; Luo HY; Wang FH; Xu RH
Tumour Biol; 2016 Feb; 37(2):1879-87. PubMed ID: 26323257
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance and prognostic value of lactate dehydrogenase A expression in gastric cancer patients.
Sun X; Sun Z; Zhu Z; Guan H; Zhang J; Zhang Y; Xu H; Sun M
PLoS One; 2014; 9(3):e91068. PubMed ID: 24608789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
